Recordati Pharmaceuticals Limited

Isis House, 43 Station Road, Henley-on-Thames, Oxfordshire, RG9 1AT, UK
Telephone: +44 (0)1491 576 336
Fax: +44 (0)1491 576 336
WWW: http://www.recordati.com
Medical Information Direct Line: +44 (0)1491 576 336
Medical Information e-mail: medinfo@recordati.co.uk

Patient Information Leaflet last updated on the eMC: 22/10/2010
PIL Urispas 200mg Film-coated Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22/10/2010 and displayed until Current
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 07/11/2008 and displayed until 22/10/2010
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 07/09/2007 and displayed until 07/11/2008
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 25/05/2006 and displayed until 07/09/2007
Reasons for adding or updating:
  • Change of distributor for the product
  • Change to warnings or special precautions for use
Updated on 03/03/2005 and displayed until 25/05/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Correction of spelling/typing errors
Updated on 01/07/2003 and displayed until 03/03/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 10/12/2001 and displayed until 01/07/2003
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   flavoxate hydrochloride